• Long-term neuroprotective effects of NT-4-engineered mesenchymal stem cells injected intravitreally in a mouse model of acute retinal injury.
  Machalińska A, Kawa M, Pius-Sadowska E, Stępniewski J, Nowak W, Rogińska D, Kaczyńska K, Baumert B, Wiszniewska B, Józkowicz A, Dulak J, Machaliński B.
  Invest Ophthalmol Vis Sci. 2013; 54: 8292-8305
  
• Type 2 diabetes mellitus impairs endothelial progenitor cells functions
  Kotlinowski J, Dulak J, Józkowicz A.
  Postepy Biochem. 2013; 59: 257-266
  
• Roles of microRNA in cell reprogramming
  Stepniewski J, Józkowicz A, Dulak J.
  Postepy Biochem. 2013; 59: 157-163
  
• Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia.
  Jazwa A, Tomczyk M, Taha HM, Hytonen E, Stoszko M, Zentilin L, Giacca M, Yla-Herttuala S, Emanueli C, Jozkowicz A, Dulak J.
  Vasc Cell. 2013; 5: 13.
  
• Murine bone marrow Lin⁻Sca⁻1⁺CD45⁻ very small embryonic-like (VSEL) cells are heterogeneous population lacking Oct-4A expression.
  Szade K, Bukowska-Strakova K, Nowak WN, Szade A, Kachamakova-Trojanowska N, Zukowska M, Jozkowicz A, Dulak J.
  PLoS One. 2013; 8: e63329.
  
• Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives.
  Karewicz A, Bielska D, Loboda A, Gzyl-Malcher B, Bednar J, Jozkowicz A, Dulak J, Nowakowska M.
  Colloids Surf B Biointerfaces. 2013; 109: 307-316
  
• Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis.
  Skrzypek K, Tertil M, Golda S, Ciesla M, Weglarczyk K, Collet G, Guichard A, Kozakowska M, Boczkowski J, Was H, Gil T, Kuzdzal J, Muchova L, Vitek L, Loboda A, Jozkowicz A, Kieda C, Dulak J.
  Antioxid Redox Signal. 2013; 19: 644-660.
  
• Gene therapy on demand: Site specific regulation of gene therapy.
  Jazwa A, Florczyk U, Jozkowicz A, Dulak J.
  Gene. 2013; 525: 229-238
  
• Therapeutic angiogenesis for revascularization in peripheral artery disease.
  Grochot-Przeczek A, Dulak J, Jozkowicz A.
  Gene. 2013; 525: 220-228.
  
• Introduction to the special issue dedicated to the founding Editor, Dr. Waclaw Szybalski.
  Dulak J, Jozkowicz A.
  Gene. 2013; 525: 147-148.
  
• 50years of gene therapy-A contribution of Wacław Szybalski to science and humanity.
  Dulak J, Uchto J, Jozkowicz A.
  Gene. 2013; 525: 149-150.
  
• Stable tumor vessel normalization with pO2 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment.
  Kieda C, El Hafny-Rahbi B, Collet G, Lamerant-Fayel N, Grillon C, Guichard A, Dulak J, Jozkowicz A, Kotlinowski J, Fylaktakidou KC, Vidal A, Auzeloux P, Miot-Noirault E, Beloeil JC, Lehn JM, Nicolau C.
  J Mol Med (Berl). 2013; 91: 883-899.
  
• Development of hyperglycemia and diabetes in captive Polish bank voles.
  Bartelik A, Ciesla M, Kotlinowski J, Bartelik S, Czaplicki D, Grochot-Przeczek A, Kurowski K, Koteja P, Dulak J, Józkowicz A.
  Gen Comp Endocrinol. 2013; 183: 69-78
  
• Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells.
  Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-Saadatmandi C, Rimbach G, Jozkowicz A, Dulak J, Loboda A.
  Mol Nutr Food Res. 2013; 57: 504-515.
  
• Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice.
  Jazwa A, Stepniewski J, Zamykal M, Jagodzinska J, Meloni M, Emanueli C, Jozkowicz A, Dulak J.
  Cardiovasc Res. 2013; 97: 115-124.
  

« 2012 | 2014 »